To obtain quantitative data for each mouse individually, we counted and determined the mean densities of LysM-EGFP+, CD11c-EYFP+, and double-labeled LysM-EGFP+/CD11c-EYFP+ cells over a volume of 100 μm depth inside the tumor for Bev-treated and untreated mice at day 21 and day 28. This evidence concerns the gene ITGAX and neoplasm.